In this session, Gwen interviews Gianna Hoffman-Luca, Principal from Xontogeny, a therapeutics focused seed-stage VC fund founded by Chris Garabedian, former CEO of Sarepta. Gianna demystifies the funding landscape for therapeutics startups, recommends companies to start solving for data necessary for series A funding, at the seed and pre-seed stage.